Share this event on:

Measuring Designer Drugs of Abuse

This presentation is now available to view on demand

The webinar will present different classes of emerging drugs of abuse (e.g. cathinones, synthetic cannabinoids, opioids) and strategies and possibilities for their detection with a focus on human urine and blood.

Furthermore, limitations will be discussed concerning different detection techniques towards certain drug classes (e.g. immunoassay). The webinar will close with perspectives on upcoming classes where no analytical data are available yet.

The participant will be informed about new drugs of abuse appeared on the market in the last years and how to detect them in various samples. The participant will also be aware of the fact that there are limitations in detecting such drugs using particular techniques.

Supported by an unrestricted educational grant from Thermo Fisher Scientific


Anthony Newman
Publisher Clinica Chimica Acta
Dr. Markus R. Meyer, PhD
Inst Pharmacology & Toxicology
Saarland University
View Bio
Yes No
Yes No
Yes No

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) required fields